| | More

2014 ATS Foundation Partner and Unrestricted Grants

ATS FOUNDATION RESEARCH GRANT APPLICATION INSTRUCTIONS

The grants and awards are explained below, along with the application process, applicant qualification requirements, instructions, timeline for the review process and submission requirements.

Please review all eligibility requirements before submitting a letter of intent or full application.

2014 Research Program Portfolio

Timeline for 2014 ATS Foundation Grants 
(Funding to begin October 31, 2014)

May 9, 2014 Deadline for submission of letters of intent (LOI); May 23, 2014 for PHA Grants
June 6, 2014 Review of the LOI’s
Mid-Late June 2014 Applicants will receive official notification on their LOI’s
July 18, 2014 Submission deadline for full grant applications
Late September, 2014 Review of grant applications
Early-Mid October 2014 Award notifications sent to applicants and institutions

Note that there will be additional grants added to the opportunities listed below.  Please subscribe to our mailing list for updates on new award opportunities.

ATS Foundation Unrestricted Research Grants

The ATS Foundation will award three (3) unrestricted research grants.  For the first time, the ATS Foundation will offer one unrestricted research award in each of the following categories: pulmonary, sleep, and critical care. Though these unrestricted awards have always been available to sleep and critical care investigators, the majority of applications have focused on pulmonary research. By committing funds to sleep and critical care research, the ATS Foundation is aiming to increase the number of high quality applications received in these areas.

The ATS Foundation encourages international and domestic applications in basic, patient-oriented, and public health topics. In the area of public health, the ATS Foundation is particularly interested in funding projects that will inform health policy decisions. These include projects that explore the quality and safety of a specific treatment and compare the effectiveness of different therapies.

For this year only, funding for these unrestricted grants will be reduced to $40,000 for one year.  Previously awarded research grants will not be affected.

Partner Grants

ATS Foundation/Alpha-1 Foundation Research Grant­ (1 grant available)

  • Co-funded by the ATS Foundation and the Alpha-1 Foundation. Please visit alpha-1foundation.org for more information about our partner.

The target audience for these research grants will be investigators interested in research that is relevant to alpha-1 antitrypsin deficiency (Alpha-1). The focus of the research grants will be programs that have a high likelihood to advance the understanding of Alpha-1. Applications are encouraged from faculty members at any stage of their academic career.  Applicants may request up to $40,000/year for 2 years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the applicant's institution.

Applicants must have completed their primary research training (PhD or sub-specialty fellowship training) by July 1, 2014 and have a firm commitment from their home institution for a faculty position.  The following individuals are not eligible for this award:

  • US-based trainees who do not hold a Visa that spans the project period of the grant
  • Current awardees of the ATS Foundation Research Program
  • Individuals who have received 2 ATS grants

ATS Foundation/American Lung Association of the Mountain Pacific Research Grant (1 grant available)

The ATS Foundation has partnered with the American Lung Association of the Mountain Pacific to fund one grant for $50,000 per year for 2 years. This award is restricted to individuals working at Oregon-based institutions, and investigators must also meet all eligibility criteria listed below.  The ATS Foundation/ALA Mountain Pacific Grants are available for junior researchers investigating lung disease, sleep, and critical care.  Both basic science and patient-oriented research proposals are encouraged.  Patient-oriented research is defined as research performed with human subjects (or on material of human origin such as tissues or other specimen). This area of research includes 1) disease mechanism; 2) therapeutic interventions; 3) clinical trials; and 4) the development of new technologies.  Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two.  Indirect costs will not be paid to the applicant’s institution.

ATS Foundation/Boehringer Ingelheim Pharmaceuticals, Inc. Career Development Award in Idiopathic Pulmonary Fibrosis (1 award available)

  • This activity is supported by a research grant from Boehringer Ingelheim Pharmaceuticals, Inc. Please visit boehringer-ingelheim.com for more information about our partner.

The Fellowship Career Development Award is designed to support the research of a fellow undergoing training in Idiopathic Pulmonary Fibrosis-directed research. Applicants should submit proposals for mentored projects addressing important areas of investigation in Idiopathic Pulmonary Fibrosis. Applicants may request up to $50,000 for one year.

Individuals who already have faculty positions are not eligible. Applicants must be enrolled in an accredited pulmonary/critical care training program and must be in good standing in the program. The goal is to support the research efforts of fellows during the latter part of their training (typically after their second year of training) in order to enhance their educational experience, advance discovery, and promote careers in academia. In line with these goals, applicants must hold a MD, DO, MD/PhD, PhD, DVM, or equivalent degree and should plan to pursue a career in academic medicine.

During the period of this award, applicants may not accept other training awards or other external funds that provide stipend or salary support for the same work outlined in their proposal. Applicants must also be a U.S. citizen or resident alien with a Permanent Resident Card ("Green Card") at the time the application is submitted.  Grant funds may not go towards indirect costs.
In addition, the following individuals are not eligible for this award:

  • US-based trainees who do not hold a Visa that spans the project period of the grant
  • Current awardees of the ATS Foundation Research Program
  • Individuals who have received 2 ATS grants

*For Applicants of the ATS Foundation/Boehringer Ingelheim Pharmaceuticals Career Development Award in Idiopathic Pulmonary Fibrosis Only: No salary or fringe benefit payments may be made from ATS Foundation funds. The granted funds support necessary incremental personnel and other direct costs/fees that are associated with conducting the research. The level of effort required for the research project must be allowed by the employing agency as part of the individuals' official duties.

ATS Foundation/Breathe California of Los Angeles Research Grant (1 award available)

  • Co-funded by the ATS Foundation and Breathe Califonia of Los Angeles. Please visit breathela.org for more information about our partner.

The American Thoracic Society Foundation/ Breathe California of Los Angeles Research Grant invite applications from early career investigators who are based in Southern California (south of Bakersfield, CA).  This grant program seeks to advance understanding and improve the diagnosis and management of Chronic Obstructive Pulmonary Disease, including but not confined to pathogenesis, pathophysiology, epidemiology, prevention, treatment and management of the disease. Applicants may request up to $40,000/year for 2 years for salaries, supplies or a combination of these two.  Indirect costs will not be paid to the applicant's institution.

ATS Foundation/Pulmonary Hypertension Association Research Fellowship (1 grant available)

  • Co-funded by the ATS Foundation and the Pulmonary Hypertension Association (PHA). Please visit phassociation.org for more information about our partner.

The target audience for this research fellowship will be investigators interested in research in pulmonary arterial hypertension. The fellowship will be directed to supporting research into the pathophysiology of PAH, toward elucidating mechanistic pathways and identifying novel therapeutic targets or biomarkers in adult or pediatric pulmonary hypertension. The project should have potential applicability to human pulmonary vascular diseases. Applicants may request up to $40,000/year for 2 years for salaries, supplies or a combination of these two. A primary goal of the ATS Foundation and PHA Research Programs is to enable new faculty-level investigators to make the transition to careers as established investigators. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their training. One of the investigators must be an ATS member at the time of application, and the Principal Investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the sponsoring institution. Investigators are also encouraged to connect through PHA's professional network, PH Clinicians and Researchers, during the course of their research. Indirect costs will not be paid to the sponsoring institution.

ATS Foundation/Pulmonary Fibrosis Foundation/Coalition for Pulmonary Fibrosis Research Grant (1 grant available)

  • Co-funded by the ATS Foundation, the Coalition for Pulmonary Fibrosis, and the Pulmonary Fibrosis Foundation. Please visit coalitionforpf.org and pulmonaryfibrosis.org for more information about our partners.

The target audience for these research grants will be domestic and international investigators interested in research that is relevant to pulmonary fibrosis. The focus of the research grant will be programs that have a high likelihood to advance the understanding of pulmonary fibrosis. Applications are encouraged from new faculty members who have a strong link with one or more senior investigator. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. One of the investigators must be an ATS member at the time of application, and the Principal Investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the applicant's institution.

ATS Foundation/Scleroderma Foundation Research Grant­ (1 grant available)

  • Co-funded by the ATS Foundation and the Scleroderma Foundation. Please visit scleroderma.org for more information about our partner.

The target audience for these research grants will be investigators interested in research that is directly relevant to lung disease that results from scleroderma (ie, systemic sclerosis or SSc). The focus of the research grants will be programs that have a high likelihood to advance the understanding of scleroderma-associated lung disease. Applications are encouraged from new faculty members who have a strong link with one or more senior investigator. Applicants may request up to $40,000/year for 2 years for salaries, supplies or a combination of these two. One of the investigators must be an ATS member at the time of application, and the Principal Investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the sponsoring institution.

ATS Foundation Tobacco-Dependence Research Fund Grant: For Research on Basic Mechanisms Involved in Tobacco Dependence (1 grant available)

  • Made possible by a generous grant from the ATS Foundation Tobacco-Dependence Research Fund.

The grant will be targeted for research on basic mechanisms involved in tobacco dependence, including such areas as neurogenetics, pharmacology, neuropharmacology, cell receptors, airway sensory responses, and other basic science areas that enhance understanding of the basic mechanisms causing tobacco dependence.  This grant is NOT intended to support studies that examine the adverse consequences of cigarette smoking. The Principal Investigator must be a member of a division of pulmonary and critical care medicine. Trans-disciplinary, cross-department collaboration is encouraged. Preference will be given to projects that, because of their novelty, require bridge funding before becoming competitive for other funding mechanisms. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. Applicants must meet the criteria listed below. A primary goal of the ATS Foundation Research Program is to enable new faculty-level investigators to make the transition to careers as established investigators. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their training. At least one of the senior investigators must also be a member of the applicant's pulmonary and critical care medicine division. Both US and non-US based investigators are encouraged to apply. At least one of the investigators must be an ATS member at the time of application, and the principal investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the sponsoring institution.

Letters of Intent are due on May 10, 2014.

ELIGIBILITY AND GUIDELINES

Please note that the ATS Foundation/Alpha-1 Foundation Research Grant and the ATS Foundation/Boehringer Ingelheim Pharmaceuticals, Inc. Career Development Award in Idiopathic Pulmonary Fibrosis award have different eligibility criteria than the other ATS Foundation partner and unrestricted grants. These criteria are listed in the description for these awards posted above. Applicants for these grants should disregard the guidelines that follow.

A primary goal of the ATS Foundation Research Program is to enable new investigators the chance to make the transition to careers as established investigators. Applicants must have completed their primary research training (PhD or sub-specialty fellowship training) by July 1, 2014 and have a firm commitment from their home institution for a faculty position. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their research training. At least one of the key personnel must be an ATS member at the time of application, and the principal investigator must be an ATS member at the time that the grant is awarded. Individuals may submit multiple letter of intent (LOI) applications, but ATS will extend at most one invitation to submit a full grant application to each applicant. Consistent with our intention to support early career investigators, applicants shall not be over 12 years beyond their doctoral degree or equivalent (i.e., MD, PhD, DVM).

Applicants shall not be the recipients of relatively large national awards defined as an NIH R01, Veterans Affairs Grant, Department of Defense Grant or equivalent awards with funding of ≥ $100,000 per year for at least 2 years from a single independent (nonmentored) grant at any time.

Investigators who hold active career development grants (such as K award from the NIH) are eligible to receive ATS research funding, but the ATS project should differ scientifically from the already funded award.
At the present time, investigators in the following categories are not eligible to apply for ATS grants:

  • US-based trainees who do not hold a Visa that spans the project period of the grant
  • Current awardees of the ATS Foundation Research Program
  • Individuals who have received 2 ATS grants

REVIEW PROCESS

The ATS Scientific Advisory Committee (SAC) will review the applications. The membership of the SAC is listed on the ATS Website. Additional ad hoc reviewers, especially in the areas of sleep and critical care, will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.

ATS POLICY ON ADDITIONAL GRANT FUNDING

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the ATS within one month of formal notification of award. A subcommittee of SAC will assess degree of overlap. In case of significant scientific overlap the applicant will have to choose between the ATS research grant and the other grant. Budgetary overlap is not allowed.

INSTRUCTIONS FOR APPLYING

Application forms are available on the Foundant Technologies website.

Please note that after you submit your application it will be reviewed by ATS staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

Please contact Stephen C. Crane, PhD, MPH, at scrane@thoracic.org with any questions related to requirements and eligibility.